Plavix (clopidogrel), to prevent recurrent MI or ischemic stroke

December 1997

    Bristol-Myers Squibb will soon promote Plavix (clopidogrel), to prevent recurrent MI or ischemic stroke.

    Plavix is a new platelet inhibitor. It's chemically similar to Ticlid (ticlopidine)...but without the risk of neutropenia.

    Plavix is slightly more effective than aspirin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote